Skip to main content

Table 2 Treatment during hospitalization

From: Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock

Variable Serum glucose level on admission  
  <7.8 mmol/l 7.8 to 10.9 mmol/l 11.0 to 16.5 mmol/l ≥16.6 mmol/l P value
  (group 1, n= 181) (group 2, n= 215) (group 3, n= 216) (group 4, n= 204)
Primary PCI 138 (76.2) 177 (82.3) 167 (77.3) 162 (79.4) 0.450
Facilitated PCI 6 (3.3) 3 (1.4) 3 (1.4) 2 (1.0) 0.380
Thrombolysis 11 (6.1) 8 (3.7) 9 (4.2) 6 (2.9) 0.470
Medical treatment 26 (14.4) 27 (12.6) 37 (17.1) 34 (16.7) 0.527
Aspirin 175 (96.7) 203 (94.4) 205 (94.9) 177 (86.8) <0.001
Clopidogrel 173 (95.6) 205 (95.3) 200 (92.6) 176 (86.3) 0.001
Low molecular weight heparin 48 (26.5) 56 (26.0) 53 (24.5) 47 (23.0) 0.852
Glycoprotein IIb/IIIa inhibitor 23 (12.7) 32 (14.9) 42 (19.4) 42 (20.6) 0.121
Beta-blockers 96 (53.0) 123 (57.2) 100 (46.3) 104 (51.0) 0.151
ACE inhibitors 92 (50.8) 107 (49.8) 101 (46.8) 95 (46.6) 0.778
Angiotensin receptor blocker 27 (14.9) 31 (14.4) 27 (12.5) 28 (13.7) 0.905
Statins 119 (65.7) 136 (63.3) 118 (54.6) 107 (52.5) 0.016
Mechanical ventilation 48 (26.5) 49 (22.8) 86 (39.8) 85 (41.7) <0.001
Intra-aortic balloon pump 38 (21.0) 46 (21.4) 66 (30.6) 63 (30.9) 0.023
Defibrillator/cardioversion 32 (17.7) 38 (17.7) 46 (21.3) 50 (24.5) 0.257
Temporary pacemaker 22 (12.2) 33 (15.3) 42 (19.4) 40 (19.6) 0.148
  1. Values presented as n (%). ACE, angiotensin converting enzyme; PCI, percutaneous coronary intervention.